Operator

Good afternoon, and thank you for standing by. Welcome to Ascend Wellness Holdings Q1 2026 Earnings Call. Before proceeding, the company would like to remind you that the following discussion and presentation contains various forward-looking statements or information. These forward-looking statements or information are subject to risks and uncertainties that may cause actual results to differ from historical or anticipated results. For more information on the risks and uncertainties, please refer to today's earnings release and Ascend's SEC and SEDAR filings, including their most recent report on Form 10-K and quarterly report on Form 10-Q.

During today's call, the company will be referring to non-GAAP financial measures such as adjusted EBITDA. Reconciliations to the most directly comparable GAAP measures are in an appendix to the presentation and in the company's earnings release.

I am pleased to introduce the Ascend management team joining us on today's call. We will begin with Sam Brill, Chief Executive Officer and Director, who will provide an overview of the key operational developments over the first quarter of 2026. After that, Roman Nemchenko, Chief Financial Officer, will review the company's financial results for the quarter.

With that, I would like to turn the call over to our first speaker, Sam Brill. Sam, please go ahead.

Samuel Brill
CEO & Director

Thank you, operator. Good afternoon, everyone, and thank you for joining today's call. On our last call, we noted that the tone around cannabis reform was shifting. That has now translated into action. On April